Literature DB >> 23105218

Levels of enzymes in leukaemic mice treated withAeromonas L-asparaginase.

P J Benny1, G Muraleedhara Kurup, K Sreejith.   

Abstract

L-asparaginase isolated in our laboratory fromAeromonas has been found to be antileukaemic. In the present study changes in the levels of serum enzymes in leukaemic mice and under treatment withAeromonas L-asparaginase has been compared. A significant increase in the levels of serum lactate dehydrogenase with tumour growth and a decrease during therapy was observed. A significant decrease in alanine transaminase activity during tumour growth and an increase during treatment was noticed. Increased levels of aspartate transaminase and alkaline phosphatase was observed during enzyme therapy. Total acid phosphatase was found to be increased during tumour growth and decreased considerably during treatment.

Entities:  

Keywords:  Aeromonas; Enzymes; L-Asparaginase; Leukaemia

Year:  1999        PMID: 23105218      PMCID: PMC3453577          DOI: 10.1007/BF02867918

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  13 in total

1.  A method for the determination of tartratelabile, prostatic acid phosphatase in serum.

Authors:  E J KING; K A JEGATHEESAN
Journal:  J Clin Pathol       Date:  1959-01       Impact factor: 3.411

2.  Alkaline Phosphatase in Human Sera and Placentae: Starch gel electrophoresis reveals many phosphatase components including a polymorphism in placentae.

Authors:  S H Boyer
Journal:  Science       Date:  1961-10-06       Impact factor: 47.728

Review 3.  L-asparaginase.

Authors:  J P Whitecar; G P Bodey; J E Harris; E J Freireich
Journal:  N Engl J Med       Date:  1970-03-26       Impact factor: 91.245

Review 4.  The transaminase tests in liver disease.

Authors:  R J Clermont; T C Chalmers
Journal:  Medicine (Baltimore)       Date:  1967-03       Impact factor: 1.889

5.  Two L-asparaginases from Escherichia coli B. Their separation, purification, and antitumor activity.

Authors:  H A Campbell; L T Mashburn; E A Boyse; L J Old
Journal:  Biochemistry       Date:  1967-03       Impact factor: 3.162

6.  Therapeutic efficacy of asparaginase encapsulated in intact erythrocytes.

Authors:  H O Alpar; D A Lewis
Journal:  Biochem Pharmacol       Date:  1985-01-15       Impact factor: 5.858

7.  Effect of the antileukemic agent L-asparaginase on thyroxine-binding globulin and albumin synthesis in cultured human hepatoma (HEP G2) cells.

Authors:  L Bartalena; E Martino; A Antonelli; A Pacchiarotti; J Robbins; A Pinchera
Journal:  Endocrinology       Date:  1986-09       Impact factor: 4.736

Review 8.  Tumor markers: value and limitations in the management of cancer patients.

Authors:  S E Bates; D L Longo
Journal:  Cancer Treat Rev       Date:  1985-09       Impact factor: 12.111

9.  Lipid metabolism in tumour bearing mice treated withAeromonas L-asparaginase.

Authors:  P J Benny; G M Kurup; K Sreejith
Journal:  Indian J Clin Biochem       Date:  1997-07

10.  The influence of L-asparaginase therapy on the fibrinolytic system.

Authors:  E Vellenga; C Kluft; N H Mulder; G Wijngaards; H O Nieweg
Journal:  Br J Haematol       Date:  1984-06       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.